Cancer

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Evinova will operate as a separate health-tech business within AstraZeneca Evinova’s globally-scaled digital health solutions are evidence-led, science-based and human…

1 year ago

BioSyent Announces the Availability of Gelclair® in Canada

New Treatment for Painful Mouth Sores Due to Cancer TherapyMISSISSAUGA, Ontario, Nov. 20, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”,…

1 year ago

Dyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in Africa

JUPITER, Fla., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI),…

1 year ago

Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer

JERUSALEM, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau") (NASDAQ: DRTS, DRTSW), the developer of the…

1 year ago

Mainz Biomed to Present at the 35th Annual Piper Sandler Healthcare Conference

BERKELEY, Calif. and MAINZ, Germany, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”),…

1 year ago

Tempest to Present at the 35th Annual Piper Sandler Healthcare Conference

BRISBANE, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-classi therapeutics…

1 year ago

Orion Animal Health receives FDA approval for Bonqat® (pregabalin oral solution)

ORION CORPORATION PRESS RELEASE 20 NOVEMBER 2023 at 15.00 EET                       Orion Animal Health receives FDA approval for Bonqat® (pregabalin oral…

1 year ago

EDAP to Present at Piper Sandler’s 35th Annual Healthcare Conference

LYON, France, November 20, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies,…

1 year ago

TRACON Pharmaceuticals Announces License of Product Development Platform for $3.0 Million Upfront Payment

SAN DIEGO, Nov. 20, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a…

1 year ago

Starton Therapeutics Completes One Third of STAR-LLD Study Enrollment

Two patients have been dosed and a third is in screeningThe first patient has completed cycle 1 successfully where he…

1 year ago